Kalmar Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-420,004
Closed -$5.54M 157
2015
Q3
$5.54M Sell
420,004
-130,162
-24% -$1.97M 0.13% 148
2015
Q2
$9.02M Sell
550,166
-40,645
-7% -$675K 0.17% 144
2015
Q1
$10.5M Buy
590,811
+480,006
+433% +$8.92M 0.2% 137
2014
Q4
$2.11M Buy
+110,805
New +$1.88M 0.04% 154

Other funds holding ANGO

Kalmar Investments's ANGO Position: Q4 2015 in Review

Kalmar Investments sold out of AngioDynamics (ANGO) in Q4 2015, closing a stake of 420,004 shares — an estimated $5.54M sold.

Kalmar Investments first reported a position in ANGO in Q4 2014 and held it in 4 quarters. The position peaked at $10.5M in Q1 2015. 121 funds tracked by Wall St. Rank hold ANGO as of Q4 2015.

  • Kalmar Investments reported no remaining AngioDynamics position as of Q4 2015 after selling out during the quarter.
  • Kalmar Investments sold 420,004 AngioDynamics shares in Q4 2015, an estimated $5.54M.
  • Kalmar Investments first reported a position in AngioDynamics in Q4 2014 and held it in 4 quarters.
  • Kalmar Investments's AngioDynamics position peaked at $10.5M in Q1 2015.
  • 121 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2015.

Based on Kalmar Investments's 13F filing for Q4 2015, filed 28 Jan 2016.